A new study, drawing on data from national biobanks, adds to the growing evidence that exposure to common viral pathogens increases the risk of Alzheimer disease and other neurodegenerative diseases. These findings might provide insights into the initiating factors that lead to neurodegeneration.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases
Nature Immunology Open Access 27 January 2026
-
Early antiviral treatment following gammaherpesvirus-68 infection of the central nervous system prevents subsequent multiple sclerosis-like disease
Journal of Neuroinflammation Open Access 08 October 2025
-
Immunological aspects of central neurodegeneration
Cell Discovery Open Access 09 April 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
19 January 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41582-024-00931-5
References
Lotz, S. K., Blackhurst, B. M., Reagin, K. L. & Funk, K. E. Microbial infections are a risk factor for neurodegenerative diseases. Front. Cell. Neurosci. 15, 691136 (2021).
Griciuc, A. & Tanzi, R. E. The role of innate immune genes in Alzheimer’s disease. Curr. Opin. Neurol. 34, 228–236 (2021).
Parhizkar, S. & Holtzman, D. M. APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease. Semin. Immunol. 59, 101594 (2022).
Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron https://doi.org/10.1016/j.neuron.2022.12.029 (2023).
Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296–301 (2022).
Readhead, B. et al. Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99, 64–82.e7 (2018).
Eimer, W. A. et al. Alzheimer’s disease-associated β-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 100, 1527–1532 (2018).
Hemmingsson, E.-S. et al. Antiviral treatment associated with reduced risk of clinical Alzheimer’s disease—a nested case-control study. Alzheimers Dement. (N.Y.) 7, e12187 (2021).
Sun, J. et al. Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: a nationwide nested case–control study in Sweden. PLoS Med. 19, e1004092 (2022).
Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease. Nature 577, 399–404 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Blackhurst, B.M., Funk, K.E. Viral pathogens increase risk of neurodegenerative disease. Nat Rev Neurol 19, 259–260 (2023). https://doi.org/10.1038/s41582-023-00790-6
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41582-023-00790-6
This article is cited by
-
Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases
Nature Immunology (2026)
-
Early antiviral treatment following gammaherpesvirus-68 infection of the central nervous system prevents subsequent multiple sclerosis-like disease
Journal of Neuroinflammation (2025)
-
Immunological aspects of central neurodegeneration
Cell Discovery (2024)
